CONTEXT: Studies have suggested that PTH may influence mortality and progression of chronic kidney disease. However, the development of either event may influence the development of the other as a competing risk. OBJECTIVE: The objective of the study was to examine the association of PTH with end-stage renal disease (ESRD) and pre-ESRD death using a competing risk survival model. DESIGN, SETTING, AND PATIENTS: A total of 10,823 participants in the Kidney Early Evaluation Program with chronic kidney disease (estimated glomerular filtration rate < 60 ml/min per 1.73 m(2)) were examined from 2005 to 2010. MAIN OUTCOME MEASURES: The association of PTH levels with ESRD and pre-ESRD mortality was ascertained by linking Kidney Early Evaluation Program data to the Social Security Administration Death Master File and the U.S. Renal Data System. RESULTS: Among the cohort, the incidence of ESRD and pre-ESRD mortality was 6.4 and 20.1 events per 1000 person-years. Higher PTH levels were associated with increasing age, black race, lack of a high school education, cardiovascular disease, hypertension, and lower glomerular filtration rate. The incidence of ESRD and pre-ESRD mortality was lowest among participants in the second PTH quintile. After multivariate adjustment, as compared with the second quintile, the risk of pre-ESRD mortality was higher in the third [subhazard ratio (SHR) 1.52 (95% confidence interval 1.04-2.22)], fourth [SHR 1.73 (95% confidence interval 1.19-2.52)], and fifth [SHR 1.86 (1.28-2.52)] quintiles, respectively. Conversely, PTH was not associated with ESRD after multivariate adjustment. The association was not modified by diabetic status, gender, race, or glomerular filtration rate status. CONCLUSIONS: Elevated PTH levels are associated with increased pre-ESRD mortality but not with ESRD.
CONTEXT: Studies have suggested that PTH may influence mortality and progression of chronic kidney disease. However, the development of either event may influence the development of the other as a competing risk. OBJECTIVE: The objective of the study was to examine the association of PTH with end-stage renal disease (ESRD) and pre-ESRD death using a competing risk survival model. DESIGN, SETTING, AND PATIENTS: A total of 10,823 participants in the Kidney Early Evaluation Program with chronic kidney disease (estimated glomerular filtration rate < 60 ml/min per 1.73 m(2)) were examined from 2005 to 2010. MAIN OUTCOME MEASURES: The association of PTH levels with ESRD and pre-ESRD mortality was ascertained by linking Kidney Early Evaluation Program data to the Social Security Administration Death Master File and the U.S. Renal Data System. RESULTS: Among the cohort, the incidence of ESRD and pre-ESRD mortality was 6.4 and 20.1 events per 1000 person-years. Higher PTH levels were associated with increasing age, black race, lack of a high school education, cardiovascular disease, hypertension, and lower glomerular filtration rate. The incidence of ESRD and pre-ESRD mortality was lowest among participants in the second PTH quintile. After multivariate adjustment, as compared with the second quintile, the risk of pre-ESRD mortality was higher in the third [subhazard ratio (SHR) 1.52 (95% confidence interval 1.04-2.22)], fourth [SHR 1.73 (95% confidence interval 1.19-2.52)], and fifth [SHR 1.86 (1.28-2.52)] quintiles, respectively. Conversely, PTH was not associated with ESRD after multivariate adjustment. The association was not modified by diabetic status, gender, race, or glomerular filtration rate status. CONCLUSIONS: Elevated PTH levels are associated with increased pre-ESRD mortality but not with ESRD.
Authors: Paul A Scott; John M Morgan; Nicola Carroll; David C Murday; Paul R Roberts; Charles R Peebles; Stephen P Harden; Nick P Curzen Journal: Circ Arrhythm Electrophysiol Date: 2011-04-14
Authors: Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Anil Jain; Martin J Schreiber; James F Simon; Titte R Srinivas; Joseph V Nally Journal: Am J Kidney Dis Date: 2011-08-04 Impact factor: 8.860
Authors: Carmen A Peralta; Keith C Norris; Suying Li; Tara I Chang; Manjula K Tamura; Stacey E Jolly; George Bakris; Peter A McCullough; Michael Shlipak Journal: Arch Intern Med Date: 2012-01-09
Authors: Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Johan Wadén; Nina Tolonen; Markku Saraheimo; Daniel Gordin; John L Moran; Merlin C Thomas; Per-Henrik Groop Journal: J Am Soc Nephrol Date: 2011-02-18 Impact factor: 10.121
Authors: Fabiana G Graciolli; Katia R Neves; Luciene M dos Reis; Rafael G Graciolli; Irene L Noronha; Rosa M A Moysés; Vanda Jorgetti Journal: Nephrol Dial Transplant Date: 2008-12-15 Impact factor: 5.992
Authors: Adam T Whaley-Connell; Manjula Kurella Tamura; Claudine T Jurkovitz; Mikhail Kosiborod; Peter A McCullough Journal: Am J Kidney Dis Date: 2013-04 Impact factor: 8.860
Authors: Alper Sonmez; Mahmut Ilker Yilmaz; Mutlu Saglam; Hilmi Umut Unal; Mahmut Gok; Hakki Cetinkaya; Murat Karaman; Cem Haymana; Tayfun Eyileten; Yusuf Oguz; Abdulgaffar Vural; Manfredi Rizzo; Peter P Toth Journal: Lipids Health Dis Date: 2015-04-16 Impact factor: 3.876
Authors: Adam Shardlow; Natasha J McIntyre; Richard J Fluck; Christopher W McIntyre; Maarten W Taal Journal: BMJ Open Date: 2017-08-23 Impact factor: 2.692